Characterisation of the cell type-specificity of collagenase 3 mRNA expression in comparison with membrane type 1 matrix metalloproteinase and gelatinase A in the synovial membrane in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 61, Issue 5, 2002, Pages 391-397

  Petrow, P K ^a   Wernicke, D ^b   Schulze Westhoff, C ^b   Hummel, K M ^c   Brauer R ^a   Kriegsmann, J ^d   Gromnica Ihle, E ^e   Gay, R E ^f   Gay, S ^f  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e Clinic of Rheumatology   (Germany)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD68 ANTIGEN; COLLAGENASE 3; GELATINASE A; MATRIX METALLOPROTEINASE 14; MESSENGER RNA;

ANTIGEN DETECTION; ARTICLE; CELL SPECIFICITY; CELL TYPE; CLINICAL ARTICLE; COMPARATIVE STUDY; ENDOTHELIUM CELL; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIUM;

ARTHRITIS, RHEUMATOID; BLOTTING, NORTHERN; COLLAGENASES; HUMANS; IN SITU HYBRIDIZATION; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNOVIAL MEMBRANE;

EID: 0036247906     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.5.391     Document Type: Article

References (35)

1. The family of matrix metalloproteinases
2. Activation mechanisms of matrix metalloproteinases
3. ECM and cell surface proteolysis: Regulating cellular ecology
4. Biochemical characterization of human collagenase 3
5. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage
6. Collagenase-3 (matrix metalloprotease-13) is preferentially localized in the deep layer of human arthritic cartilage in situ: In vitro mimicking effect by transforming growth factor beta
7. Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis
8. Matrix metalloproteinase-13 (collagenase 3) in human rheumatoid synovium
9. Comparative immunolocalization studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro
10. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
11. Cellular mechanisms for human procollagenase 3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme
12. The soluble catalytic domain of membrane type-1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3
13. Expression and regulation of collagenase 3 (MMP-13) in human malignant tumors
14. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage
15. Collagenase 3 (MMP-13) and its activators in rheumatoid arthritis: Localization in the pannus-hard tissue junction and inhibition by alendronate
16. New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: Destruction from above
17. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in rheumatoid synovium
18. Characterization of collagenase 3 (matrix metalloproteinase-13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis
19. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
20. Characterization and isolation of poly- and monoclonal antibodies against collagen for use in immunohistochemistry
21. A new double labeling technique for combined in situ hybridization and immunohistochemical analysis
22. Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis
23. Distinct populations of stromal cells express collagenase 3 (MMP-13) and collagenase 1 (MMP-1) in chronic ulcers but not in normally healing wounds
24. The role of the C-terminal domain of human collagenase 3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction
25. The TIMP-2 membrane type-1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study
26. Clinical significance of expression of membrane type-1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma
27. Expression of integrin alpha(v)beta(3) correlates with activation of membrane type-1 matrix metalloproteinase (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo
28. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: Different profiles in trauma and rheumatoid arthritis
29. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
30. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells
31. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions
32. Expression of collagenase 3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck
33. Analysis and promoter characterization of the human collagenase 3 gene (MMP-13)
34. Cloning, sequencing and characterization of the 5′-flanking region of the human collagenase 3 gene
35. Differential effects of transforming growth factor-beta on the expression of collagenase 1 and collagenase 3 in human fibroblasts